Amgen Inc.
AMGN | NASDAQ
$393.16
+$7.51 (+1.95%)
At close: Sep 21, 2026, 4:00 PM ET
$392
-$1.16 (-0.30%)
After-hours:
Sep 21, 2026, 7:59 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 36.74B | 33.42B | 28.19B | 26.32B | 25.98B | 25.42B |
Cost of Revenue | 10.73B | 12.86B | 8.42B | 6.41B | 6.45B | 6.16B |
Gross Profit | 26.01B | 20.57B | 19.78B | 19.92B | 19.53B | 19.27B |
Operating Income | 10.68B | 7.26B | 7.9B | 9.57B | 7.64B | 9.14B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 8.98B | 4.61B | 7.86B | 7.35B | 6.7B | 8.13B |
Net Income | 7.71B | 4.09B | 6.72B | 6.55B | 5.89B | 7.26B |
Selling & General & Admin | 7.05B | 7.1B | 6.18B | 5.41B | 5.37B | 5.73B |
Research & Development | 6.97B | 5.96B | 4.78B | 4.43B | 6.32B | 4.21B |
Other Expenses | 1.31B | 248M | 879M | 503M | 194M | 189M |
Operating Expenses | 15.34B | 13.31B | 11.84B | 10.35B | 11.89B | 10.13B |
Interest Expense | 2.76B | 3.16B | 2.88B | 1.41B | 1.2B | 1.26B |
Selling & Marketing Expenses | n/a | 987M | n/a | 841M | 843M | n/a |
Cost & Expenses | 26.07B | 26.17B | 20.29B | 16.76B | 18.34B | 16.29B |
Income Tax Expense | 1.27B | 519M | 1.14B | 794M | 808M | 869M |
Shares Outstanding (Basic) | 538M | 541M | 535M | 538M | 570M | 586M |
Shares Outstanding (Diluted) | 542M | 541M | 538M | 541M | 573M | 590M |
EPS (Basic) | 14.33 | 7.62 | 12.56 | 12.18 | 10.34 | 12.40 |
EPS (Diluted) | 14.23 | 7.56 | 12.49 | 12.11 | 10.28 | 12.31 |
EBITDA | 16.9B | 13.36B | 14.8B | 12.17B | 11.3B | 13B |
EBIT | 11.73B | 7.76B | 10.73B | 8.75B | 7.9B | 9.4B |
Depreciation & Amortization | 5.17B | 5.59B | 4.07B | 3.42B | 3.4B | 3.6B |
Add to Watchlist
Select watchlists to add or remove AMGN